AOD-9604 — Experimental Peptide for Fat Metabolism Research

Human Growth Hormone Fragment | Lipolysis Research | Metabolic Investigation

Product Overview

AOD-9604 is a synthetic 16-amino-acid peptide derived from the C-terminal region of human growth hormone (HGH), corresponding to amino acid residues 176–191.

Originally developed as an investigational compound for obesity management, AOD-9604 has attracted scientific interest for its potential effects on lipid metabolism, particularly the regulation of fat breakdown and fat storage.

The peptide was designed to investigate whether certain metabolic actions associated with human growth hormone could be separated from its growth-promoting effects.

Proposed Mechanism of Action

AOD-9604 has been studied for its potential influence on two important metabolic processes:

• Lipolysis: The breakdown of stored triglycerides within adipose tissue, releasing fatty acids that may subsequently be used for energy.

• Lipogenesis: The biological process through which the body synthesizes and stores fat. Preclinical research has investigated whether AOD-9604 can influence this process.

• Growth Hormone-Related Metabolic Signaling: AOD-9604 was developed to explore selected fat-metabolism effects associated with HGH without reproducing its full growth-promoting activity.

• Glucose Metabolism: Research has investigated whether AOD-9604 can influence lipid metabolism without the same effects on blood glucose regulation associated with full-length growth hormone.

These proposed mechanisms are based primarily on experimental findings and do not establish clinically meaningful fat loss in humans.

Preclinical & Clinical Research

AOD-9604 has been investigated in laboratory studies, animal models, and human clinical trials involving obesity and metabolic regulation.

Early preclinical findings suggested possible effects on fat metabolism. However, subsequent clinical development did not establish sufficient weight-loss efficacy to support its approval as an obesity treatment.

Its potential effects on body composition, long-term metabolic function, and safety remain insufficiently established for clinical use.

Research Applications

AOD-9604 has been studied in several areas of metabolic research:

• Lipid Metabolism: Investigation of biological pathways involved in fat breakdown and storage.

• Adipose Tissue Biology: Exploration of metabolic responses in fat cells.

• Human Growth Hormone Fragment Research: Examination of the biological activity of selected HGH-derived peptide sequences.

• Obesity Research: Investigation of experimental approaches to regulating adipose tissue metabolism.

• Glucose and Metabolic Signaling: Study of potential interactions between lipid metabolism and glucose regulation.

These are experimental research applications, not established therapeutic indications.

Development Status & Safety

AOD-9604 is an investigational peptide and is not approved as a medication for obesity treatment or routine human use.

Although it has undergone human clinical investigation, its safety and effectiveness for weight management have not been established to the standard required for regulatory approval.

Potential concerns include insufficient long-term safety data, uncertainties regarding different administration routes, and limited evidence supporting clinically meaningful reductions in body fat.

AOD-9604 should not be presented as a proven fat-burning treatment or as a safe alternative to approved weight-management therapies.

Research Use Only

FOR SCIENTIFIC RESEARCH PURPOSES ONLY.

Intended exclusively for qualified professionals conducting legitimate laboratory and scientific investigations.

Not for human or veterinary use. Not intended for ingestion, injection, self-administration, or therapeutic application.

Not intended to diagnose, treat, cure, or prevent any disease.

PEPTITAN — PRECISION. SCIENCE. RESEARCH.